Search Results for "poverty guidelines"
Displaying 121 - 140 of 154 results. 20 results shown per page. Page 7 of 8.
CDC — Fluoroquinolone: Request for Correction (RFC)
Publication Date
Requestor: Kent McClure Organizational Affiliation: Animal Health Institute Date of request: 12/13/2002 Description of Information:
CDC — Fluoridation: Request for Correction (RFC)
Publication Date
From: To: InfoQuality@cdc.gov Date: Tue, 19 Nov 2002 Subject: information quality request for correction of influential scientific information
OPHS — Medical Marijuana: Interim Response, April 12, 2006
Publication Date
Date: April 12, 2006 To: Joseph D. Elford, Esq. Americans for Safe Access Dear Mr. Elford: Your appeal of the denial of your Request for Corrections under the Office of Public Health and Science (OPHS) Guidelines for Ensuring the Quality of Information Disseminated to the Public, received by OPHS on May 20, 2005 is still under review.
OPHS — Medical Marijuana: Interim Response, February 7, 2006
Publication Date
Date: February 7, 2006 To: Joseph D. Elford, Esq. Americans for Safe Access Dear Mr. Elford: Your appeal of the denial of your Request for Corrections under the Office of Public Health and Science (OPHS) Guidelines for Ensuring the Quality of Information Disseminated to the Public, received by OPHS on May 20, 2005 is still under review.
SAMHSA — Smokeless Tobacco Risks: Interim Response
Publication Date
Date: March 2, 2006 To: Kenneth F. Boehm, Chairman National Legal and Policy Center Dear Mr. Boehm:
OPHS — Medical Marijuana: Interim Response, December 8, 2005
Publication Date
Date: December 8, 2005 Joseph D. Elford, Esq. Americans for Safe Access Dear Mr. Elford: Your appeal of the denial of your Request for Corrections under the Office of Public Health and Science (OPHS) Guidelines for Ensuring the Quality of Information Disseminated to the Public, received by OPHS on May 20, is still under review.
OPHS — Medical Marijuana: Interim Response, July 28, 2005
Publication Date
Date: July 28, 2005 To: Joseph D. Elford, Esq. Americans for Safe Access Dear Mr. Elford:
CDC/ATSDR — Illinois Beach Park Assessment: Interim Response, September 23, 2005
Publication Date
Date: September 23, 2005 Dear
NTP — Atrazine: Interim Response, August 26, 2005
Publication Date
Date: August 26, 2005 To: Jim J. Tozzi, Center for Regulatory Effectiveness Re: June 24, 2005, Request for Reconsideration submitted by the Center for Regulatory Effectiveness on Atrazine Dear Mr. Tozzi:
SAMHSA — Smokeless Tobacco Risks: HHS Response to Rfc
Publication Date
Date: May 10, 2006 To: Kenneth F. Boehm, Chairman National Legal and Policy Center Dear Mr. Boehm: Thank you for your "Request for Correction of Information" under the Substance Abuse and Mental Health Administration Guidelines for Ensuring the Quality of Information Disseminated to the Public. This office received your request on December 22, 2005.
NTP — Naphthalene: Interim Response, August 26, 2005
Publication Date
From: August 26, 2005 To: Ms. Courtney M. Price, Vice President, CHEMSTAR, American Chemistry Council Re: February 22, 2005, Request for Reconsideration Submitted by the American Chemistry Council Regarding Naphthalene Dear Ms. Price:
CF — Grantee Abstinence Curricula: Interim Response
Publication Date
Date: November 17, 2005 To: James Wagoner, President, Advocates for Youth William Smith, Vice President, Sexuality Information Education Council of the US Re: Data quality challenge and request to cease sponsorship of non-compliant Community-Based Abstinence Education grantees Mr. Wagoner and Mr. Smith:
FDA — OMEGA Letter: Interim Response, September 20, 2005
Publication Date
Date: September 20, 2005 Jay Davis, President, Omega Laboratories, Inc. RE: Request for Correction (Removal) of Information Found On the OIVD Section of the FDA Web Site Dear Mr. Davis:
NTP — Atrazine: HHS Response to Withdrawal Request, January 4, 2006
Publication Date
Date: January 4, 2006 To: Jim J. Tozzi Center for Regulatory Effectiveness Re: Withdrawal of June 2005 Center for Regulatory Effectiveness Request for Reconsideration on Atrazine Dear Mr. Tozzi:
NTP — Atrazine: Interim Response, Date: May 16, 2005
Publication Date
Date: May 16, 2005 To: Jim J. Tozzi, Center for Regulatory Effectiveness, Suite 700, DuPont Circle Washington, D.C. 20036 Re: Request for Correction ofInformation submitted by the Center for Regulatory Effectiveness to NIH Dear Mr. Tozzi:
NTP — Naphthalene: Interim Response, April 22, 2005
Publication Date
Date: April 22, 2005 To: Ms. Courtney M. Price, Vice President, CHEMSTAR, American Chemistry Council 1300 Wilson Blvd, Arlington, Virginia 22209 Re: February 22, 2005, Request for Reconsideration Submitted by the American Chemistry Council Regarding Naphthalene Dear Ms. Price:
NTP–Anthraquinone Study: Interim Response
Publication Date
From: Public Health Service, Nalional lnstitutes of Health, Office of Science Policy Date: April 11, 2005 To: Mr. Ken Ballinger ,Vice President, Airepel Re: January 18, 2005, Request for Correction ofInfonnation submitted by Airepcl to NIH regarding Anthraquinone Dear Mr. Ballinger:
NTP — Atrazine: Interim Response, March 14, 2005
Publication Date
From: Public Health Service, Nalional lnstitutes of Health, Office of Communications and Public Liaison Date: March 14, 2005 To: Jim J. Tozzi, Center for Regulatory Effectiveness Re: Request for Correction ofInforrnation submitted by the Center for Regulatory Effectiveness to NIH Dear Mr. Tozzi:
OPHS — Medical Marijuana: Interim Response, Apri15, 2005
Publication Date
Apri15,2005 Joseph D.Elford, Esq.Americans, for Safe AccessP.O. Box 427112San Francisco, CA 94142 RE: Request for Correction of Information submitted by HHS Regarding the Medical Use of Marijuana Dear Mr. Elford:
NTP — Vinyl Chloride: Interim Response, September 2, 2004
Publication Date
September 2, 2004 Courtney M. Price Vice President, CHEMSTAR 1300 Wilson Boulevard Arlington, VA 22209 Re: Request for Correction of Information submitted by the American Chemistry Council to NIH Dear Ms. Price: